9,464
Participants
Start Date
May 20, 2024
Primary Completion Date
August 1, 2024
Study Completion Date
August 31, 2024
arm A - angiotensin converting enzyme inhibitors (ACEi)
"Patients with ACEi monotherapy before or within 6 months following debulking surgery.~ACEi will be defined as any drugs from the Anatomical Therapeutic Classification C09AA with an indication for hypertension, including but not limited to: captopril, enalapril, lisinopril, perindopril, ramipril, quinapril"
arm B - calcium channel blockers (CCBs)
"Patients with CCB monotherapy before or within 6 months following debulking surgery.~CCBs will be defined as any drugs from the Anatomical Therapeutic Classification C08CA with an indication for hypertension, including but not limited to: amlodipine, felodipine, isradipine, nicardipine, nifedipine"
arm R - angiotensin receptor blockers ARB
"Patients with angiotensin receptor blocker (ARB) before or within 6 months following debulking surgery.~ARBs will be defined as any drugs from the Anatomical Therapeutic Classification C09CA with an indication for hypertension, including but not limited to: losartan, valsartan, irbesartan, candesartan or olmesartan medoxomil."
Institut Curie, Paris
Pitié-Salpêtrière, Paris
Dr Floriane Jochum, Principal Investigator
UNKNOWN
Institut Curie
OTHER
Groupe Hospitalier Pitie-Salpetriere
OTHER